[30] Use and specificity of genistein as inhibitor of protein-tyrosine kinases
- 1 January 1991
- book chapter
- Published by Elsevier in Methods in Enzymology
- Vol. 201, 362-370
- https://doi.org/10.1016/0076-6879(91)01032-w
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- PDGF-Induced Activation of Phospholipase C Is Not Required for Induction of DNA SynthesisScience, 1990
- T Cell Antigen Receptor-Mediated Activation of Phospholipase C Requires Tyrosine PhosphorylationScience, 1990
- Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activityBiochemical Pharmacology, 1990
- Inhibitors for protein-tyrosine kinases, ST638 and genistein, induce differentiation of mouse erythroleukemia cells in a synergistic MannerExperimental Cell Research, 1989
- Induction of in vitro differentiation of mouse embryonal carcinoma (F9) and erythroleukemia (MEL) cells by herbimycin A, an inhibitor of protein phosphorylation.The Journal of cell biology, 1989
- Phospholipase C-γ is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitroCell, 1989
- EGF induces tyrosine phosphorylation of phospholipase C-II: A potential mechanism for EGF receptor signalingCell, 1989
- Inhibition of tyrosine protein kinase activity by synthetic isoflavones and flavones.The Journal of Antibiotics, 1989
- Effect of genistein on topoisomerase activity and on the growth of [VAL 12]Ha-ras-transformed NIH 3T3 cellsBiochemical and Biophysical Research Communications, 1988
- High-performance liquid chromatography separation of soybean isoflavones and their glucosidesJournal of Chromatography A, 1982